MedPath

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa

Not Applicable
Withdrawn
Conditions
Onchocerciasis
Diagnoses Disease
Loiasis
Neglected Diseases
Interventions
Diagnostic Test: LTS-2 DEC patch
Diagnostic Test: Skin snips
Registration Number
NCT04035174
Lead Sponsor
Center for Research on Filariasis and Other Tropical Diseases, Cameroon
Brief Summary

This study aims at evaluating the diagnosis performances of the LTS-2 DEC patch for onchocerciasis compared to the gold standard which are the skin snips. This study will be conducted in Cameroon in two different areas : Ngog-Mapubi and Bafia Health Districts (one area only endemic for onchocerciasis, and one area endemic for both loiasis and onchocerciasis).

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
1400
Inclusion Criteria
  • All voluntary adults
Exclusion Criteria
  • General acute infection (temperature ≥ 38,5°C)
  • Impaired general condition
  • Ivermectin taken in the 6 last months
  • Known allergies to one of the component of the patch
  • Dermatological acute infection (bacterial, atopic, prurigo, or zona)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Skin snipSkin snipsA skin snip will be performed using a 2 mm Holth corneoscleral's punch. Once done, the microfilariae of Onchocerca volvulus will be counted with a microscope.
LTS-2 DEC patchLTS-2 DEC patchThis is a transdermal device with diethylcarbamazine (DEC) applied directly on the skin. The reading will be done 24 hours after.
LTS-2 DEC patchSkin snipsThis is a transdermal device with diethylcarbamazine (DEC) applied directly on the skin. The reading will be done 24 hours after.
Skin snipLTS-2 DEC patchA skin snip will be performed using a 2 mm Holth corneoscleral's punch. Once done, the microfilariae of Onchocerca volvulus will be counted with a microscope.
Primary Outcome Measures
NameTimeMethod
Feasibility of the patch24 hours

Proportion of individuals for whom the patches are spontaneously removed from the skin during the 24 hours.

Tolerability of the patch24 hours

Proportion of individuals having developed a generalized Mazzotti's reaction

Secondary Outcome Measures
NameTimeMethod
Diagnosis performances24 hours

Assessment of the sensibility, specificity, and predictive values of the LTS-2 DEC patch compared to the results from the skin snips.

Loiasis and cross-reactivity assessment24 hours

Loiasis impact of the diagnosis performances of the LTS-2 DEC patch. Loiasis will be assessed with thick blood smears and a microscopic examination ; and with PCR in the skin snips

Semi-quantitative scoring of the LTS-2 DEC patch results24 hours

Relationship between the number of microfilariae of O. volvulus and the skin reaction under the patch (0 no reaction, 1: \< 50% of the skin under the patch, 2: \>50% of the skin under the patch, and 3: reaction under all the skin surface of the patch)

Trial Locations

Locations (1)

Centre de Recherche sur les filarioses et autres maladies tropicales (CRFilMT)

🇨🇲

Yaoundé, Cameroon

© Copyright 2025. All Rights Reserved by MedPath